Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Venetoclax Tablets, 10 mg, 50 mg, and 100 mg, expanding its generic drug portfolio.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Valganciclovir for Oral Solution, expanding its generic drug portfolio.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Prucalopride Tablets, 1 mg and 2 mg, expanding its generic drug portfolio.
Alembic Pharmaceuticals Limited (APLLTD) announces USFDA final approval for Dapsone Gel, 5%, expanding its generic drug portfolio.
Alembic Pharmaceuticals Limited (NSE: APLLTD) secures USFDA final approval for Haloperidol Tablets, expanding its generic drug portfolio.
Alembic Pharmaceuticals Limited (APLLTD) announces USFDA final approval for its Levothyroxine Sodium Tablets, expanding its generic drug portfolio.